Cargando…

Galectin-3 as an Arrhythmogenic Predictive Marker for Heart Failure

Detalles Bibliográficos
Autores principales:	Inoue, Keiko, Tajiri, Kazuko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Japanese Society of Internal Medicine 2022
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9038463/ https://www.ncbi.nlm.nih.gov/pubmed/35370252 http://dx.doi.org/10.2169/internalmedicine.8411-21

Ejemplares similares

Galectin-3 in Heart Failure: More Answers or More Questions?
por: Ahmad, Tariq, et al.
Publicado: (2012)

Predicting Heart Failure in Arrhythmogenic Right Ventricular Cardiomyopathy
por: Wang, Weijia, et al.
Publicado: (2022)

Predicting Heart Failure in Arrhythmogenic Right Ventricular Cardiomyopathy
por: Hylind, Robyn J., et al.
Publicado: (2020)

Heart Failure in Patients with Arrhythmogenic Cardiomyopathy
por: Chen, Shi, et al.
Publicado: (2021)

Galectin-3 in Cardiac Remodeling and Heart Failure
por: de Boer, Rudolf A., et al.
Publicado: (2010)

Fibrotic Marker Galectin-3 Identifies Males at Risk of Developing Cancer and Heart Failure
por: van den Berg, Pieter F., et al.
Publicado: (2023)

Prognostic Cardiac Magnetic Resonance Markers of Left Ventricular Involvement in Arrhythmogenic Cardiomyopathy for Predicting Heart Failure Outcomes
por: Chun, Kyeong‐Hyeon, et al.
Publicado: (2022)

Prognostic Value of Galectin-3 in Patients with Heart Failure
por: Bošnjak, Ivica, et al.
Publicado: (2015)

Erratum to: Galectin-3 in Cardiac Remodeling and Heart Failure
por: de Boer, Rudolf A., et al.
Publicado: (2012)

Obesity, Galectin‐3, and Incident Heart Failure: The ARIC Study
por: Florido, Roberta, et al.
Publicado: (2022)

Galectin‐3 and Risk of Heart Failure and Death in Blacks and Whites
por: McEvoy, John W., et al.
Publicado: (2016)

Galectin-3: a novel biomarker for the prognosis of heart failure
por: AMIN, HILMAN ZULKIFLI, et al.
Publicado: (2017)

What’s New in Arrhythmogenic Cardiomyopathies
por: Çimen, Tolga, et al.
Publicado: (2022)

Predictive value of plasma galectin-3 levels in heart failure with reduced and preserved ejection fraction
por: de Boer, Rudolf A, et al.
Publicado: (2011)

Galectin-3 Activation and Inhibition in Heart Failure and Cardiovascular Disease: An Update
por: Suthahar, Navin, et al.
Publicado: (2018)

Galectin-3 and Risk for Cancer or Heart Failure: Does Sex Matter?
por: Fabiani, Iacopo, et al.
Publicado: (2023)

The prognostic role of galectin-3 and endothelial function in patients with heart failure
por: Tsigkou, Vasiliki, et al.
Publicado: (2023)

Galectin-3 Inhibition in COVID-19
por: Reddy, Kiran, et al.
Publicado: (2022)

Heart rate – A complex prognostic marker in acute heart failure
por: Olligs, Jan, et al.
Publicado: (2019)

The Predictive Value of Plasma Brain Natriuretic Peptide and Galectin-3 in Elderly Patients Admitted for Heart Failure †
por: Testa, Marzia, et al.
Publicado: (2018)

A Diverse Range of Cardiac Adverse Events Associated with Immune Checkpoint Inhibitor Therapy
por: Murakata, Yoshiko, et al.
Publicado: (2022)

A Lack of Biomarkers for Cardiac Complications of Immune Checkpoint Inhibitor Therapy
por: Li, Siqi, et al.
Publicado: (2020)

Neoplastic Cardiac Tamponade
por: Osawa, Takumi, et al.
Publicado: (2023)

Novel Risk Prediction Model to Determine Adverse Heart Failure Outcomes in Arrhythmogenic Right Ventricular Cardiomyopathy
por: Chen, Shi, et al.
Publicado: (2022)

Arrhythmogenic Remodeling in the Failing Heart
por: Husti, Zoltán, et al.
Publicado: (2021)

Renal Function Impact in the Prognostic Value of Galectin-3 in Acute Heart Failure
por: Caravaca Perez, Pedro, et al.
Publicado: (2022)

Levels of Galectin-3 in Chronic Heart Failure: A Case-Control Study
por: Khadeja Bi, Altaff, et al.
Publicado: (2022)

Renal Handling of Galectin‐3 in the General Population, Chronic Heart Failure, and Hemodialysis
por: Meijers, Wouter C., et al.
Publicado: (2014)

Mechanisms responsible for increased circulating levels of galectin-3 in cardiomyopathy and heart failure
por: Nguyen, My-Nhan, et al.
Publicado: (2018)

Prognostic Value of Serial Galectin‐3 Measurements in Patients With Acute Heart Failure
por: van Vark, Laura C., et al.
Publicado: (2017)

Comparison the Prognostic Value of Galectin-3 and Serum Markers of Cardiac Extracellular Matrix Turnover in Patients with Chronic Systolic Heart Failure
por: Chang, Yi-Yao, et al.
Publicado: (2014)

Exercise: A Risky Subject in Arrhythmogenic Cardiomyopathy
por: Cerrone, Marina
Publicado: (2018)

Acylation‐stimulating protein and heart failure progression in arrhythmogenic right ventricular cardiomyopathy
por: Ren, Jie, et al.
Publicado: (2022)

Impact of Renal Denervation on Atrial Arrhythmogenic Substrate in Ischemic Model of Heart Failure
por: Yamada, Shinya, et al.
Publicado: (2018)

Arrhythmogenic Mechanisms in Heart Failure: Linking β-Adrenergic Stimulation, Stretch, and Calcium
por: Johnson, Daniel M., et al.
Publicado: (2018)

Atrial tachyarrhythmias and heart failure events in patients with arrhythmogenic right ventricular cardiomyopathy
por: Kikuchi, Noriko, et al.
Publicado: (2020)

Characterization of a porcine model of atrial arrhythmogenicity in the context of ischaemic heart failure
por: Clauss, Sebastian, et al.
Publicado: (2020)

Galectin-3 not Galectin-9 as a candidate prognosis marker for hepatocellular carcinoma
por: Kong, Fei, et al.
Publicado: (2020)

Galectin-3 level predicts response to ablation and outcomes in patients with persistent atrial fibrillation and systolic heart failure
por: Clementy, Nicolas, et al.
Publicado: (2018)

Diffuse Myocardial Fibrosis on Cardiac Magnetic Resonance Imaging Is Related to Galectin-3 and Predicts Outcome in Heart Failure
por: Screever, Elles M., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_udne16q408eagq4s7tis06imil